Integrating AI, RNA Vaccines, and CAR‐T Cells for Personalized Treatment
Oncology is undergoing a profound transformation driven by the convergence of artificial intelligence (AI), RNA‐based vaccines, and chimeric antigen receptor T‐cell (CAR‐T) therapies. Individually, these technologies have advanced cancer diagnosis, treatment, and patient stratification. AI‐driven approaches enhance dru...